Patent details

93073 Product Name: Acide benzoïque 3-{6-{[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino}-3-methylpyridin-2-yl}, ou un sel pharmaceutiquement acceptable de celui-ci, ou un pro-médicament de type ester de celui-ci.

Basic Information

Publication number:
93073
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP101915759
Legal Status:
Inactive
Application number:
93073
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1059
Marketing Authorization Type:
Marketing Authorization Date:
24/11/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
17/05/2016
First Marketing Authorization date:
24/11/2015
Grant date:
18/07/2016
Activation date:
Publication date:
18/07/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/11/2030
SPC Extension Expiration:
24/11/2030
Rejection date:
Withdrawal date:

Owner

From:
17/05/2016
 
 

Name:
Vertex Pharmaceuticals Inc.
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
17/05/2016
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Bear Brian
Address:
United States (US)

2

Name:
Zhou Jinglan
Address:
United States (US)

3

Name:
Hadidda Ruah Sara
Address:
United States (US)

4

Name:
Miller Mark
Address:
United States (US)

5

Name:
McCarthy Jason
Address:
United States (US)

6

Name:
Grootenhuis Peter, D., J.
Address:
United States (US)

7

Name:
Hamilton Matthew
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages